HIGHLIGHTS
- Who: Stephanie Best from the (UNIVERSITY) have published the research: Reanalysis of genomic data in rare disease: current practice and attitudes among Australian clinical and laboratory genetics services, in the Journal: (JOURNAL) of 25/05/2024
- Future: Automation of the process will be essential to gain the full diagnostic benefits of reanalysis for existing and future rare disease genomic datasets thus maximizing the value of investments in research and clinical sequencing.
SUMMARY
Reanalyzing stored genomic data over time is highly effective in increasing diagnostic yield in rare disease. Regular reanalysis of . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.